MEDS Trxade Group, Inc.

Trxade Group, Inc. provides an on-line platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focuses on the United States pharmaceutical industry. It operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services; provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration; and acts as technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Land O' Lakes, FL.

As of 05/11/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Discretionary
Industry:  Pharmaceutical Retailers
Index country:  USA
Country of incorporation:  USA
IPO date:  08/15/2019
Outstanding shares:  8,093,199
Average volume:  75,665
Market cap:   $30,349,496
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    89846A207
ISIN:        US89846A2078
Sedol:      BLKQN61
Valuation   (See tab for details)
PE ratio:   -8.51
PB ratio:   3.49
PS ratio:   1.69
Return on equity:   -41.06%
Net income %:   -18.74%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy